Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Rossi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 23, 2021
Ultrasound-assisted investigation of photon triggered vaporization of poly(vinylalcohol) phase-change nanodroplets: A preliminary concept study with dosimetry perspectiveYosra Toumia, Roberto Miceli, Fabio Domenici, et al.
Oncotarget|April 4, 2015
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesisVeronica De Simone, Giulia Ronchetti, Eleonora Franzè, et al.
Cell Death & Disease|March 17, 2017
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell deathVeronica De Simone, Gerolamo Bevivino, Silvia Sedda, et al.
International Journal of Cancer|October 28, 2014
HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinomaAnna Aureli, Angelica Canossi, Tiziana Del Beato, et al.
Journal of Translational Medicine|April 19, 2015
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patientsMonica Benvenuto, Pierpaolo Sileri, Piero Rossi, et al.
Medical Oncology (Northwood, London, England)|May 4, 2018
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum saltVincenzo Formica, Michaela Benassi, Giovanna Del Vecchio Blanco, et al.
Internal and Emergency Medicine|February 8, 2021
Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancerGiovanna Del Vecchio Blanco, Rami Dwairi, Mario Giannelli, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerGiuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Experimental Hematology & Oncology|February 18, 2025
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Journal of Clinical Medicine|April 14, 2026
Clinical Characteristics at the Diagnosis of New Primary Melanoma in Italy: A Multicenter Retrospective Study Before and After the COVID-19 PandemicElisabetta Pennacchioli, Luca Nespoli, Dario Piazzalunga, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 23, 2021
Ultrasound-assisted investigation of photon triggered vaporization of poly(vinylalcohol) phase-change nanodroplets: A preliminary concept study with dosimetry perspectiveYosra Toumia, Roberto Miceli, Fabio Domenici, et al.
Oncotarget|April 4, 2015
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesisVeronica De Simone, Giulia Ronchetti, Eleonora Franzè, et al.
Cell Death & Disease|March 17, 2017
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell deathVeronica De Simone, Gerolamo Bevivino, Silvia Sedda, et al.
International Journal of Cancer|October 28, 2014
HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinomaAnna Aureli, Angelica Canossi, Tiziana Del Beato, et al.
Journal of Translational Medicine|April 19, 2015
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patientsMonica Benvenuto, Pierpaolo Sileri, Piero Rossi, et al.
Medical Oncology (Northwood, London, England)|May 4, 2018
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum saltVincenzo Formica, Michaela Benassi, Giovanna Del Vecchio Blanco, et al.
Internal and Emergency Medicine|February 8, 2021
Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancerGiovanna Del Vecchio Blanco, Rami Dwairi, Mario Giannelli, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerGiuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Experimental Hematology & Oncology|February 18, 2025
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Journal of Clinical Medicine|April 14, 2026
Clinical Characteristics at the Diagnosis of New Primary Melanoma in Italy: A Multicenter Retrospective Study Before and After the COVID-19 PandemicElisabetta Pennacchioli, Luca Nespoli, Dario Piazzalunga, et al.
Pageof 7